$8.23
2.88%
Nasdaq, Sep 28, 04:25 pm EDT. Closed.
ISIN
US67092M2089
Symbol
NTRB

Nutriband Stock price

$8.23
+3.77 84.53% 1M
+4.77 137.86% 6M
+3.69 81.28% YTD
+1.17 16.57% 1Y
+6.23 311.50% 3Y
+2.23 37.17% 5Y
+3.70 81.85% 10Y
+3.70 81.85% 20Y
Nasdaq, Closing price Mon, Sep 28 2026
+0.23 2.88%
ISIN
US67092M2089
Symbol
NTRB
Industry

Is Nutriband a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
$100.0m
Enterprise Value
$96.2m
Net debt
positive
Cash
$3.4m
Shares outstanding
12.2m
Valuation (TTM | estimate)
P/E
negative
P/S
61.8 | 1.0
EV/Sales
59.4 | 1.0
EV/FCF
negative
P/B
16.7
Financial Health
Equity Ratio
88.5%
Return on Equity
-449.8%
ROCE
-131.0%
ROIC
-330.8%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$1.6m | $97.3m
EBITDA
$-6.9m
EBIT
$-7.0m
Net Income
$-7.0m
Free Cash Flow
$-3.6m
Growth (TTM | estimate)
Revenue
-37.2% | 4,670.5%
EBITDA
-5.3%
EBIT
-3.5%
Net Income
78.3%
Free Cash Flow
26.7%
Margin
Gross
33.1%
EBITDA
-426.5%
EBIT
-435.6%
Net
-430.4%
Free Cash Flow
-224.5%
More
EPS
$-0.6
FCF per Share
$-0.3
Short interest
3.4%
Employees
13
Rev per Employee
$160.0k

Nutriband Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Nutriband forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Nutriband forecast:

Buy
86%
Hold
14%

Financial data from Nutriband

Jul '26
+/-
%
1.62 1.62
37% 37%
100%
- Direct Costs 1.08 1.08
36% 36%
67%
0.54 0.54
39% 39%
33%
- Selling and Administrative Expenses 6.37 6.37
25% 25%
393%
- Research and Development Expense 1.21 1.21
54% 54%
75%
-6.90 -6.90
5% 5%
-426%
- Depreciation and Amortization 0.15 0.15
42% 42%
9%
EBIT (Operating Income) EBIT -7.05 -7.05
4% 4%
-435%
Net Profit -6.96 -6.96
78% 78%
-430%

In millions USD.

Don't miss a Thing! We will send you all news about Nutriband directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nutriband Stock News

Neutral
GlobeNewsWire
●
7 days ago
ORLANDO, Fla., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) confirmed today that its outstanding warrants (NASDAQ:NTRBW) will expire on September 30, 2026 at 5PM ET as scheduled.
Neutral
GlobeNewsWire
●
20 days ago
ORLANDO, Fla., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO, Gareth Sheridan will attend the inaugural Nasdaq LaB Biotech Summit on September 16th.
Neutral
GlobeNewsWire
●
21 days ago
Nutriband has received a Notice of Publication from the United States Patent and Trademark Office (USPTO) for commercial brand name trademarks for its lead product, an abuse deterrent fentanyl transdermal system. Once allowed, Nutriband plans to submit its commercial worldwide brand name to the FDA and other international regulatory agencies for approval.
More Nutriband News

Company Profile

Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It delivers abuse deterrent fentanyl transdermal system which provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. It operates through the Pocono Coated Products and Active Intelligence segments. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2016 and is headquartered in Orlando, FL.

Head office United States
CEO Mr. Sheridan
Employees 13
Founded 2012
Website nutriband.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today